PL2206698T3 - Związki etynyloindolowe - Google Patents

Związki etynyloindolowe

Info

Publication number
PL2206698T3
PL2206698T3 PL09180244T PL09180244T PL2206698T3 PL 2206698 T3 PL2206698 T3 PL 2206698T3 PL 09180244 T PL09180244 T PL 09180244T PL 09180244 T PL09180244 T PL 09180244T PL 2206698 T3 PL2206698 T3 PL 2206698T3
Authority
PL
Poland
Prior art keywords
ethynylindole
compounds
ethynylindole compounds
Prior art date
Application number
PL09180244T
Other languages
English (en)
Polish (pl)
Inventor
Ohmoto Kazuyuki
Itadani Satoshi
Nakayama Yoshisuke
Takeuchi Jun
Fujita Manabu
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of PL2206698T3 publication Critical patent/PL2206698T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
PL09180244T 2008-12-22 2009-12-21 Związki etynyloindolowe PL2206698T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008325815 2008-12-22
EP09180244A EP2206698B1 (en) 2008-12-22 2009-12-21 Ethynylindole compounds

Publications (1)

Publication Number Publication Date
PL2206698T3 true PL2206698T3 (pl) 2012-12-31

Family

ID=42110130

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09180244T PL2206698T3 (pl) 2008-12-22 2009-12-21 Związki etynyloindolowe

Country Status (18)

Country Link
US (1) US8115014B2 (enExample)
EP (1) EP2206698B1 (enExample)
JP (2) JP5012884B2 (enExample)
KR (1) KR101464778B1 (enExample)
CN (1) CN101759628B (enExample)
AU (1) AU2009250960C1 (enExample)
BR (1) BRPI0905601A2 (enExample)
CA (1) CA2688614C (enExample)
DK (1) DK2206698T3 (enExample)
ES (1) ES2387185T3 (enExample)
IL (1) IL202869A (enExample)
MX (1) MX2009013926A (enExample)
NZ (1) NZ582208A (enExample)
PL (1) PL2206698T3 (enExample)
PT (1) PT2206698E (enExample)
RU (1) RU2505531C2 (enExample)
TW (1) TWI469965B (enExample)
ZA (1) ZA200909096B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8598223B2 (en) * 2010-06-21 2013-12-03 Ono Pharmaceutical Co., Ltd. Crystalline forms of 4, 4′-[4-fluoro-7-({4-[4-(3-fluoro-2-methylphenyl) butoxy] phenyl} ethynyl)-2-methyl-1H-indole-1,3-diyl] dibutanoic acid, 4,4′-[2-methyl-7-({4-[4-(pentafluorophenyl) butoxy] phenyl} ethynyl)-1H-indole-1, 3-diyl] dibutanoic acid, and 4,4′-[4-fluoro-2-methyl-7-({4-[4-(2, 3, 4, 6-tetrafluorophenyl) butoxy] phenyl} ethynyl)-1H-indole-1, 3-diyl] dibutanoic acid
KR101171790B1 (ko) 2010-07-30 2012-08-13 현대자동차주식회사 인출식 자전거 캐리어
LT2658844T (lt) 2010-12-28 2017-02-10 Sanofi Nauji pirimidino dariniai, jų gamyba ir jų farmacinis panaudojimas kaip akt (pkb) fosforilinimo slopiklių
EP2537866A1 (en) * 2011-06-21 2012-12-26 Serumwerk Bernburg AG Hydroxyethyl starch derivatives, method for manufacturing the same and therapeutical uses thereof
CN103893146A (zh) * 2012-12-25 2014-07-02 天津药物研究院 含福多司坦缓释剂型
US11427591B2 (en) * 2018-10-17 2022-08-30 Insilico Medicine Ip Limited Kinase inhibitors
WO2021221111A1 (ja) * 2020-04-30 2021-11-04 国立大学法人京都大学 Rnaウイルス関連疾患の予防又は治療剤

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (enExample) 1956-03-21 1900-01-01
US3095355A (en) 1961-10-12 1963-06-25 Revlon Aerosol composition
JPH01192476A (ja) 1988-01-25 1989-08-02 Kawasaki Steel Corp 溶接鋼管の製造方法
US5137910A (en) 1989-05-05 1992-08-11 C.D. Searle & Co. Compositions containing indole-2-carboxylate compounds for treatment of CNS disorders
JPH0347123A (ja) 1989-05-05 1991-02-28 G D Searle & Co インドール―2―カルボキシレート化合物類を含有するcns疾患治療用組成物
US5229413A (en) 1989-05-05 1993-07-20 G. D. Searle & Co. Compositions containing indole-2-carboxylate compounds for treatment of CNS disorders
CA2019335C (en) 1989-06-27 2000-08-01 Mitoshi Konno Phenylalkan (en)oic acids
GB9027018D0 (en) * 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds
US5530019A (en) 1993-04-05 1996-06-25 Fujisawa Pharmaceutical Co., Ltd. Indole derivatives useful as testosterone 5α-reductase inhibitors
WO1997013751A1 (en) 1995-10-10 1997-04-17 Pfizer Inc. Indole carbamates as leukotriene antagonists
FR2766824B1 (fr) 1997-07-30 1999-09-10 Adir Nouveaux composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB9902455D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
US6608059B1 (en) 2000-06-27 2003-08-19 Smithkline Beecham Corporation Fatty acid synthase inhibitors
JP2003025362A (ja) 2001-07-18 2003-01-29 Nippon Tokushu Toryo Co Ltd 通気性を有する発泡プラスチック及びその製法
US6867224B2 (en) 2002-03-07 2005-03-15 Warner-Lambert Company Compounds that modulate PPAR activity and methods of preparation
AU2003214462A1 (en) 2002-04-03 2003-10-13 Astrazeneca Ab Indole derivatives having anti-angiogenetic activity
AU2003239150A1 (en) 2002-04-23 2003-11-10 Aventis Pharmaceuticals Inc. 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo
SE0202241D0 (sv) 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
EP1628970A2 (en) 2003-04-30 2006-03-01 The Institutes of Pharmaceutical Discovery, LLC Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
US7763610B2 (en) * 2003-09-01 2010-07-27 Ono Pharmaceutical Co., Ltd. Carboxylic acid derived benzoxazines as agents for the treatment of respiratory diseases
RU2416601C2 (ru) * 2005-02-25 2011-04-20 Оно Фармасьютикал Ко., Лтд. Соединение индола и его применение

Also Published As

Publication number Publication date
US8115014B2 (en) 2012-02-14
AU2009250960B2 (en) 2013-09-05
CN101759628B (zh) 2013-02-27
CN101759628A (zh) 2010-06-30
NZ582208A (en) 2011-05-27
JP2010168359A (ja) 2010-08-05
PT2206698E (pt) 2012-08-03
MX2009013926A (es) 2010-06-22
KR20100074036A (ko) 2010-07-01
KR101464778B1 (ko) 2014-11-24
RU2505531C2 (ru) 2014-01-27
EP2206698B1 (en) 2012-07-18
CA2688614C (en) 2015-01-06
TWI469965B (zh) 2015-01-21
BRPI0905601A2 (pt) 2012-05-02
US20100160647A1 (en) 2010-06-24
DK2206698T3 (da) 2012-08-27
ES2387185T3 (es) 2012-09-17
AU2009250960C1 (en) 2014-01-23
ZA200909096B (en) 2010-09-29
JP2012144546A (ja) 2012-08-02
JP5012884B2 (ja) 2012-08-29
RU2009147506A (ru) 2011-06-27
AU2009250960A1 (en) 2010-07-08
EP2206698A1 (en) 2010-07-14
TW201026664A (en) 2010-07-16
IL202869A (en) 2015-02-26
CA2688614A1 (en) 2010-06-22

Similar Documents

Publication Publication Date Title
GB0807862D0 (en) Compounds
GB0812648D0 (en) Compounds
GB0800035D0 (en) Compounds
GB0809776D0 (en) Compounds
IL202869A (en) Etinylindole Compounds
GB0800367D0 (en) Compounds
GB0807910D0 (en) Compounds
GB0801220D0 (en) Compounds
GB0801265D0 (en) Compounds
GB0811203D0 (en) Compounds
GB0807047D0 (en) Compounds
GB0808669D0 (en) Compounds
GB0811029D0 (en) Compounds
GB0810619D0 (en) Compounds
GB0810118D0 (en) Compounds
GB0811449D0 (en) Compounds
GB0811450D0 (en) Compounds
GB0812640D0 (en) Compounds
GB0809771D0 (en) Compounds
GB0808471D0 (en) Inseticidal compounds
GB0808123D0 (en) Compounds
GB0808119D0 (en) Compounds
GB0807911D0 (en) Compounds
GB0812646D0 (en) Compounds
GB0812675D0 (en) Compounds